| Richard Hughes, DO | |
|
80 Highland St, Laconia, NH 03246-3235 | |
| (603) 524-3211 | |
| Not Available |
| Full Name | Richard Hughes |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 47 Years |
| Location | 80 Highland St, Laconia, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235200130 | NPI | - | NPPES |
| 30221124 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 11154 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presbyterian Santa Fe Medical Center | Santa fe, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of New Mexico P C | 4385536564 | 68 |
News Archive
Scientists from St. Jude Children's Research Hospital and the Children's Oncology Group (COG) have discovered in children with acute lymphoblastic leukemia (ALL) scores of inherited genetic variations that clinicians might be able to use as guideposts for designing more effective chemotherapy for this cancer.
Researchers at the University of Chicago have discovered there is extensive gene "traffic"—the process of genes leaving and arriving on the chromosome—on the mammalian X chromosome. They also have overturned a conventional theory about how genes evolved on the sex chromosome.
Atherosclerosis is the underlying condition that causes heart attacks and strokes. Researchers at Radboudumc in the Netherlands have discovered a protein that appears to play an important role in atherosclerosis.
KLOX Technologies Inc. is pleased to announce that it has received CE mark approval in Europe for its topical photo-converter gel as a Class IIa Medical Device for the treatment of acne vulgaris, including all severities. The gel is part of KLOX's LumiCleanse System, a first-in-class innovative, non-invasive acne vulgaris treatment with a clinically-proven superior safety and efficacy profile. The LumiCleanseTM System was previously approved for the treatment of all severities of acne vulgaris in Canada in September of this year.
Currently, there is no treatment to halt the progression of Huntington's disease (HD), a fatal genetic disorder that slowly robs sufferers of their physical and mental abilities. Now, researchers at University of California, San Diego School of Medicine have discovered that an existing compound, previously tested for diabetes, offers hope for slowing HD and its symptoms.
› Verified 1 days ago
| Entity Name | Anesthesia Associates Of New Mexico P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912900754 PECOS PAC ID: 4385536564 Enrollment ID: O20040325000455 |
News Archive
Scientists from St. Jude Children's Research Hospital and the Children's Oncology Group (COG) have discovered in children with acute lymphoblastic leukemia (ALL) scores of inherited genetic variations that clinicians might be able to use as guideposts for designing more effective chemotherapy for this cancer.
Researchers at the University of Chicago have discovered there is extensive gene "traffic"—the process of genes leaving and arriving on the chromosome—on the mammalian X chromosome. They also have overturned a conventional theory about how genes evolved on the sex chromosome.
Atherosclerosis is the underlying condition that causes heart attacks and strokes. Researchers at Radboudumc in the Netherlands have discovered a protein that appears to play an important role in atherosclerosis.
KLOX Technologies Inc. is pleased to announce that it has received CE mark approval in Europe for its topical photo-converter gel as a Class IIa Medical Device for the treatment of acne vulgaris, including all severities. The gel is part of KLOX's LumiCleanse System, a first-in-class innovative, non-invasive acne vulgaris treatment with a clinically-proven superior safety and efficacy profile. The LumiCleanseTM System was previously approved for the treatment of all severities of acne vulgaris in Canada in September of this year.
Currently, there is no treatment to halt the progression of Huntington's disease (HD), a fatal genetic disorder that slowly robs sufferers of their physical and mental abilities. Now, researchers at University of California, San Diego School of Medicine have discovered that an existing compound, previously tested for diabetes, offers hope for slowing HD and its symptoms.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Hughes, DO Po Box 1328, Auburn, ME 04211-1328 Ph: (207) 784-9185 | Richard Hughes, DO 80 Highland St, Laconia, NH 03246-3235 Ph: (603) 524-3211 |
News Archive
Scientists from St. Jude Children's Research Hospital and the Children's Oncology Group (COG) have discovered in children with acute lymphoblastic leukemia (ALL) scores of inherited genetic variations that clinicians might be able to use as guideposts for designing more effective chemotherapy for this cancer.
Researchers at the University of Chicago have discovered there is extensive gene "traffic"—the process of genes leaving and arriving on the chromosome—on the mammalian X chromosome. They also have overturned a conventional theory about how genes evolved on the sex chromosome.
Atherosclerosis is the underlying condition that causes heart attacks and strokes. Researchers at Radboudumc in the Netherlands have discovered a protein that appears to play an important role in atherosclerosis.
KLOX Technologies Inc. is pleased to announce that it has received CE mark approval in Europe for its topical photo-converter gel as a Class IIa Medical Device for the treatment of acne vulgaris, including all severities. The gel is part of KLOX's LumiCleanse System, a first-in-class innovative, non-invasive acne vulgaris treatment with a clinically-proven superior safety and efficacy profile. The LumiCleanseTM System was previously approved for the treatment of all severities of acne vulgaris in Canada in September of this year.
Currently, there is no treatment to halt the progression of Huntington's disease (HD), a fatal genetic disorder that slowly robs sufferers of their physical and mental abilities. Now, researchers at University of California, San Diego School of Medicine have discovered that an existing compound, previously tested for diabetes, offers hope for slowing HD and its symptoms.
› Verified 1 days ago
Dr. Matthew V Buck, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 | |
Dr. Matthew J Harris, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 80 Highland Street, Laconia, NH 03247 Phone: 603-524-3211 | |
Robert Evans, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 | |
Eric T Meyer, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 | |
Nancy Kressin, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 |